REG-BARCLAYS PLC Form 8.3 - STERIS CORP <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Form 8.3 - STERIS CORP
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code)
1. KEY INFORMATION
| (a) | Full name of discloser: | Barclays PLC. | ||||||
| (b) | Owner or controller of interest and short | |||||||
| positions disclosed, if different from 1(a): | ||||||||
| (c) | Name of offeror/offeree in relation to whose | STERIS CORP | ||||||
| relevant securities this form relates: | ||||||||
| (d) | If an exempt fund manager connected with an | |||||||
| offeror/offeree, state this and specify identity of | ||||||||
| offeror/offeree: | ||||||||
| (e) | Date position held/dealing undertaken: | 14 October 2015 | ||||||
| (f) | In addition to the company in 1(c) above, is the discloser making | YES: | ||||||
| disclosures in respect of any other party to the offer? | SYNERGY HEALTH PLC | |||||||
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
| Class of relevant security: | ORD | |||||||||||
| Interests | Short Positions | |||||||||||
| Number | (%) | Number | (%) | |||||||||
| (1) | Relevant securities owned | |||||||||||
| and/or controlled: | 2,903 | 0.00% | 286,610 | 0.48% | ||||||||
| (2) | Cash-settled derivatives: | |||||||||||
| 284,112 | 0.47% | 0 | 0.00% | |||||||||
| (3) | Stock-settled derivatives (including options) | |||||||||||
| and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | ||||||||
| TOTAL: | 287,015 | 0.48% | 286,610 | 0.48% | ||||||||
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).
(b) Rights to subscribe for new securities (including directors and other employee options)
| Class of relevant security in relation to which subscription right exists: | |
| Details, including nature of the rights concerned and relevant percentages: |
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| security | securities | ||||||
| ORD | Purchase | 1 | 66.2100 USD | ||||
| ORD | Purchase | 100 | 65.2700 USD | ||||
| ORD | Purchase | 100 | 65.6600 USD | ||||
| ORD | Purchase | 152 | 65.2300 USD | ||||
| ORD | Purchase | 188 | 65.2646 USD | ||||
| ORD | Purchase | 200 | 65.7550 USD | ||||
| ORD | Purchase | 200 | 66.3600 USD | ||||
| ORD | Purchase | 300 | 65.6466 USD | ||||
| ORD | Purchase | 307 | 65.7271 USD | ||||
| ORD | Purchase | 400 | 66.8672 USD | ||||
| ORD | Purchase | 400 | 65.7600 USD | ||||
| ORD | Purchase | 442 | 66.1275 USD | ||||
| ORD | Purchase | 500 | 65.8040 USD | ||||
| ORD | Purchase | 504 | 65.4010 USD | ||||
| ORD | Purchase | 700 | 65.7900 USD | ||||
| ORD | Purchase | 1,100 | 65.5972 USD | ||||
| ORD | Purchase | 1,341 | 65.2643 USD | ||||
| ORD | Purchase | 1,642 | 66.1551 USD | ||||
| ORD | Purchase | 2,400 | 65.6110 USD | ||||
| ORD | Purchase | 2,800 | 65.9689 USD | ||||
| ORD | Purchase | 2,800 | 65.6236 USD | ||||
| ORD | Purchase | 3,200 | 65.9352 USD | ||||
| ORD | Purchase | 4,599 | 65.5059 USD | ||||
| ORD | Purchase | 4,700 | 65.6229 USD | ||||
| ORD | Sale | 1 | 66.2100 USD | ||||
| ORD | Sale | 34 | 65.4400 USD | ||||
| ORD | Sale | 40 | 65.3500 USD | ||||
| ORD | Sale | 55 | 65.3372 USD | ||||
| ORD | Sale | 100 | 65.6500 USD | ||||
| ORD | Sale | 121 | 65.6900 USD | ||||
| ORD | Sale | 150 | 65.4366 USD | ||||
| ORD | Sale | 200 | 65.0650 USD | ||||
| ORD | Sale | 259 | 65.4017 USD | ||||
| ORD | Sale | 400 | 65.3987 USD | ||||
| ORD | Sale | 759 | 65.3615 USD | ||||
| ORD | Sale | 800 | 65.5593 USD | ||||
| ORD | Sale | 800 | 65.6543 USD | ||||
| ORD | Sale | 1,100 | 65.5549 USD | ||||
| ORD | Sale | 1,300 | 65.6585 USD | ||||
| ORD | Sale | 1,400 | 65.9192 USD | ||||
| ORD | Sale | 1,440 | 65.5699 USD | ||||
| ORD | Sale | 1,493 | 65.2300 USD | ||||
| ORD | Sale | 1,907 | 65.8228 USD | ||||
| ORD | Sale | 2,200 | 65.6035 USD | ||||
| ORD | Sale | 2,450 | 66.6877 USD | ||||
| ORD | Sale | 2,479 | 65.6229 USD | ||||
| ORD | Sale | 4,200 | 65.7552 USD | ||||
| ORD | Sale | 5,388 | 65.6151 USD |
(b) Cash-settled derivative transactions
| Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
(ii) Exercise
| Class of relevant security | Product description e.g. call option | Exercising/ exercised against | Number of securities | Exercise price per unit |
(d) Other dealings (including subscribing for new securities)
| Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) |
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none |
(c) Attachments
| Is a Supplemental Form 8 (Open Positions) attached? | NO | |||
| Date of disclosure: | 15 Oct 2015 | |||
| Contact name: | Jay Supaya | |||
| Telephone number: | 020 7773 0635 | |||
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151015006148/en/
BARCLAYS PLC
Recent news on Steris
See all newsREG - Travelex Financing - Update on debt restructuring
AnnouncementREG - Synergy Health Steris Corp. - Scheme Effective <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - State Street Global Steris Corp. Synergy Health - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - Legal&Gen Inv Mgmnt Synergy Health Steris Corp. - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Announcement